Jayanth Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 11-12-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.78 Cr
as on 11-12-2024
- Satisfied Charges ₹ 11.87 Cr
as on 11-12-2024
- Revenue 2.70%
(FY 2023)
- Profit 100.15%
(FY 2023)
- Ebitda -22.24%
(FY 2023)
- Net Worth 18.50%
(FY 2023)
- Total Assets 19.34%
(FY 2023)
About Jayanth Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹26.78 Cr. The company has closed loans amounting to ₹11.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Koti Baireddy, Baireddy Jaya, Ravi Baireddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2002PTC038432
- Company No.
038432
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jayanth Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koti Baireddy  | Managing Director | 31-Jan-2002 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Baireddy Jaya | Whole-Time Director | 19-May-2018 | Current |
| Ravi Baireddy | Whole-Time Director | 30-Sep-2018 | Current |
| Nitya Dasaram | Whole-Time Director | 30-Sep-2018 | Current |
Financial Performance of Jayanth Pharmaceuticals.
Jayanth Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.7% increase. The company also saw a substantial improvement in profitability, with a 100.15% increase in profit. The company's net worth Soared by an impressive increase of 18.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jayanth Pharmaceuticals?
Unlock access to Jayanth Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jayanth Life Sciences Private LimitedActive 13 years 9 monthsKoti Baireddy and Baireddy Jaya are mutual person
- J.K. Chemlabs Private LimitedActive 13 years 9 months
Koti Baireddy, Baireddy Jaya and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 31 Mar 2023 | ₹8.20 Cr | Open |
Indian Bank Creation Date: 19 Oct 2022 | ₹16.88 Cr | Open |
Hdfc Bank Limited Creation Date: 31 May 2022 | ₹1.17 M | Open |
How Many Employees Work at Jayanth Pharmaceuticals?
Jayanth Pharmaceuticals has a workforce of 13 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jayanth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jayanth Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
